TVM Life Science Management
Munich, Germany · Seed → Growth
Their stated focus (public profile)
TVM Capital Life Science is a venture capital firm focused exclusively on life sciences, employing a dual-pronged investment strategy. The first prong involves forming single-asset project-focused companies around early-stage therapeutics in partnership with Eli Lilly and Company to reach clinical proof of concept efficiently. The second prong targets commercial-stage medtech, diagnostics, digital health, and late-stage therapeutics with differentiated products poised to reach major inflection points. Key therapeutic focus areas include oncology, immunology, diabetes, CNS/neurodegeneration, pain, cardiovascular diseases, and rare diseases.
Stages: Seed → Growth
Sectors: Life sciences, Medtech, Healthtech
On file: 3 partners on record · 18 companies on record
Website: tvm-capital.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.